139 related articles for article (PubMed ID: 36704593)
1. Refractory Hypercalcemia in a Patient with End Stage Renal Disease.
Prabhahar A; Sethi J; Ancil S; Rastogi P; Singh T
Indian J Nephrol; 2022; 32(6):642-643. PubMed ID: 36704593
[No Abstract] [Full Text] [Related]
2. Refractory hypercalcemia due to an ectopic mediastinal parathyroid gland in a hemodialysis patient: a case report.
Shen Y; Fei P
BMC Nephrol; 2019 May; 20(1):165. PubMed ID: 31088386
[TBL] [Abstract][Full Text] [Related]
3. Use of denosumab to treat refractory hypercalcemia in a peritoneal dialysis patient with immobilization and tertiary hyperparathyroidism.
Pratt RM; West ML; Tennankore KK
Perit Dial Int; 2020 Jan; 40(1):103-106. PubMed ID: 32063140
[TBL] [Abstract][Full Text] [Related]
4. Use of Pamidronate to Treat Hypercalcemia in an Oncology Dialysis Patient: A Case Report.
Mahmoud S; Mitwally H; El Zeer HS; El Madhoun I; Khatib M
Am J Case Rep; 2018 Sep; 19():1087-1089. PubMed ID: 30209247
[TBL] [Abstract][Full Text] [Related]
5. Denosumab for treatment of immobilization-related hypercalcemia in a patient with end-stage renal disease.
Uehara A; Yazawa M; Kawata A; Hachisuka R; Shibagaki Y
CEN Case Rep; 2017 May; 6(1):111-114. PubMed ID: 28509133
[TBL] [Abstract][Full Text] [Related]
6. Fine-tuned continuous renal replacement therapy with calcium-free dialysate to manage severe hypercalcemia refractory to medical and intermittent hemodialysis.
Scheen M; Nowak G; Sanchez B; Teta D
Eur J Med Res; 2022 Jun; 27(1):89. PubMed ID: 35676731
[TBL] [Abstract][Full Text] [Related]
7. Symptomatic hypercalcemia of immobilization in a patient with end-stage renal disease.
Gopal H; Sklar AH; Sherrard DJ
Am J Kidney Dis; 2000 May; 35(5):969-72. PubMed ID: 10793036
[TBL] [Abstract][Full Text] [Related]
8. Hypercalcemia and elevated serum 1.25-dihydroxyvitamin D in an end-stage renal disease patient with pulmonary cryptococcosis.
Wang IK; Shen TY; Lee KF; Chang HY; Lin CL; Chuang FR
Ren Fail; 2004 May; 26(3):333-8. PubMed ID: 15354986
[TBL] [Abstract][Full Text] [Related]
9. Treatment of severe hypercalcemia due to refractory hyperparathyroidism in renal transplant patients with the calcimimetic agent cinacalcet.
Apostolou T; Damianou L; Kotsiev V; Drakopoulos S; Hadjiconstantinou V
Clin Nephrol; 2006 May; 65(5):374-7. PubMed ID: 16724661
[TBL] [Abstract][Full Text] [Related]
10. Primary hyperoxaluria in an adult presenting with end-stage renal failure together with hypercalcemia and hypothyroidism.
Karadag S; Gursu M; Aydin Z; Uzun S; Dogan O; Ozturk S; Kazancioglu R
Hemodial Int; 2011 Oct; 15(4):573-6. PubMed ID: 22111829
[TBL] [Abstract][Full Text] [Related]
11. A case of hypercalcemia because of adrenal insufficiency induced by glucocorticoid withdrawal in a patient undergoing hemodialysis.
Oyama Y; Iwafuchi Y; Narita I
CEN Case Rep; 2022 Feb; 11(1):73-78. PubMed ID: 34319567
[TBL] [Abstract][Full Text] [Related]
12. Hypercalcemia of malignancy with simultaneous elevation in serum parathyroid hormone--related peptide and 1,25-dihydroxyvitamin D in a patient with metastatic renal cell carcinoma.
Shivnani SB; Shelton JM; Richardson JA; Maalouf NM
Endocr Pract; 2009 Apr; 15(3):234-9. PubMed ID: 19364692
[TBL] [Abstract][Full Text] [Related]
13. Management and prognostic significance of hypercalcemia in renal cell carcinoma.
Chasan SA; Pothel LR; Huben RP
Urology; 1989 Mar; 33(3):167-70. PubMed ID: 2521966
[TBL] [Abstract][Full Text] [Related]
14. Unusual cause of hypercalcaemia in end stage renal failure patients.
Teo HK; Wong J
Hemodial Int; 2017 Apr; 21(2):E40-E44. PubMed ID: 27866377
[TBL] [Abstract][Full Text] [Related]
15. Effective long-term management of parathyromatosis-related refractory hypercalcemia with a combination of denosumab and cinacalcet treatment.
Tzotzas T; Goropoulos A; Karras S; Terzaki A; Siolos A; Doumas A; Zaramboukas T; Tigas S
Hormones (Athens); 2022 Mar; 21(1):171-176. PubMed ID: 34993886
[TBL] [Abstract][Full Text] [Related]
16. Unexpected hypercalcemia in a diabetic patient with kidney disease.
Lupica R; Buemi M; Campennì A; Trimboli D; Canale V; Cernaro V; Santoro D
World J Nephrol; 2015 Jul; 4(3):438-43. PubMed ID: 26167468
[TBL] [Abstract][Full Text] [Related]
17. Disseminated Histoplasmosis Presenting as Weight Loss and Hypercalcemia in a Renal Transplant Patient With Prior History of Subtotal Parathyroidectomy.
Gani I; Barrett A; Mulloy L; Kapoor R
Am J Med Sci; 2021 Mar; 361(3):383-387. PubMed ID: 33729918
[TBL] [Abstract][Full Text] [Related]
18. Hypercalcemia and elevated 1,25-(OH)2D levels in a patient with end-stage renal disease and active tuberculosis.
Fuss M; Karmali R; Bergman P; Gillet C; Prigogine T; Schmerber J; Brauman H; Corvilain J; Dierckx P
N Engl J Med; 1985 Jun; 312(23):1520-1. PubMed ID: 3838800
[No Abstract] [Full Text] [Related]
19. Neuroendocrine Carcinoma as a Cause of Humoral Hypercalcemia of Malignancy: A Case of a Patient With Elevated Parathyroid Hormone-Related Protein.
Christensen BR; Rendo MJ; Beeler BW; Huddleston BJ; Fenderson JL
Cureus; 2022 Mar; 14(3):e23398. PubMed ID: 35481321
[TBL] [Abstract][Full Text] [Related]
20. Hypercalcemia and elevated 1,25-dihydroxyvitamin D levels in a patient with end-stage renal disease and active tuberculosis.
Gkonos PJ; London R; Hendler ED
N Engl J Med; 1984 Dec; 311(26):1683-5. PubMed ID: 6548798
[No Abstract] [Full Text] [Related]
[Next] [New Search]
